A tumour sensitivity assay, the differential staining cytotoxicity (DiSC) assay, which has been shown to have potential in predicting tumour response to cytotoxic drugs, has been used to investigate the radiosensitivity of peripheral blood lymphocytes isolated from patients with chronic lymphocytic leukaemia (CLL). The isolated lymphocytes were irradiated and incubated for 4 days. Radiation-induced cell kill was assessed by differential staining of dead and live cells with subsequent calculation of tumour cell viability. The results of 61 CLL specimens from 40 patients are reported, showing profound inter-patient differences in the sensitivity of cells to radiation. Five patient specimens, which were radioresistant in vitro, were from patients who were also resistant clinically to irradiation. Another patient who responded very well clinically was found to be extremely sensitive in the assay.
A tumour sensitivity assay, the differential staining cytotoxicity (DiSC) assay, which has been shown to have potential in predicting tumour response to cytotoxic drugs, has been developed to investigate the radiosensitivity of peripheral blood lymphocytes isolated from patients with chronic lymphocytic leukaemia (CLL). The method involved irradiating isolated lymphocytes (0.64-20.48 Gy at 8 x 10(5) cells/ml) and incubating for 4 days. Subsequent radiation-induced cell kill was assessed by differential staining of dead and live cells and calculation of tumour cell viability. Factors affecting assay success rate and in vitro radioresponse were investigated. Results were shown to be reproducible both when repeat assays were performed on the same specimen on the same day, and on different specimens from the same patient after intervening periods of time. Greater than 1 day transit time (whole blood) or storage (separated cells in medium) was found to be detrimental to assay success, but pH of the medium (either pH 7.3 or 8) had little effect. An increased incubation period (from 4 to 7 days) slightly reduced cell survival, but the underlying radioresponsiveness of the cells did not change.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.